TCL Archive Ethicists dispute von Eschenbach’s claim that his NCI-FDA conflicts are managed. NCI-FDA chief appears to cite Klausner-era “in-box rule.” December 16, 2005
TCL Archive AACI Opposes Most Guidelines Proposals But Can’t Agree On Research Based Ceiling May 2, 1980
TCL Archive FDA Approves Gilotrif Tablets in NSCLC, Boehringer Ingelheim’s First Approved Cancer Drug July 26, 2013
